Sort   by:  
 Page size 
UnknownPembrolizumab in classical Hodgkin's lymphoma.
Not available
S-EPMC4987237 | biostudies-literature
UnknownPembrolizumab and its role in relapsed/refractory classical Hodgkin's lymphoma: evidence to date and clinical utility.
Not available
S-EPMC5881987 | biostudies-literature
UnknownEmerging treatment options for the management of Hodgkin's lymphoma: clinical utility of nivolumab.
Not available
S-EPMC5436782 | biostudies-literature
UnknownEvaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date.
Not available
S-EPMC7351990 | biostudies-literature
UnknownNovel targeted therapies for mantle cell lymphoma.
Not available
S-EPMC3326650 | biostudies-literature
UnknownTBL1X: At the crossroads of transcriptional and posttranscriptional regulation.
Not available
S-EPMC9929687 | biostudies-literature
UnknownDesign, Synthesis, and Biological Evaluation of Selective TBL1X Degraders.
Not available
S-EPMC11472461 | biostudies-literature
UnknownT Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia.
Not available
S-EPMC10525033 | biostudies-literature
UnknownSOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma.
Not available
S-EPMC12744261 | biostudies-literature
UnknownModulation of immune checkpoint molecule expression in mantle cell lymphoma.
Not available
S-EPMC6773518 | biostudies-literature
Sort   by:  
 Page size